NCT00805922
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Bangkok, Thailand
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
158 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00000620
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +16 more
- Locations
-
- Minneapolis Medical Research Foundation Minneapolis, Minnesota, United States
- Columbia University New York, United States
- Wake Forest University Winston-Salem, North Carolina, United States
- Case Western Reserve University Cleveland, Ohio, United States
NCT01495013
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Ipoh, Malaysia
- GSK Investigational Site Johor Bahru, Malaysia
- GSK Investigational Site Kuala Lumpur, Malaysia
- GSK Investigational Site Kubang Kerian, Malaysia
NCT01285518
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Profil Institute for Clinical Research, Inc. Chula Vista, California, United States
- Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Fort Meyers, Florida, United States
- Elite Research Institute Miami, Florida, United States
- Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Miramar, Florida, United States
NCT00102388
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Investigative Site Investigative Centers, Germany
- Novartis Pharmaceuticals Basel, Switzerland
NCT00138606
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
- Novartis Investigative Site Investigative Centers, Germany
NCT00351884
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
- Novartis Investigative Site Investigative Centers, Germany
NCT00138567
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Investigative Site East Hanover, New Jersey, United States
- Novartis Investigative site Investigative Centers, Germany
NCT00396227
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
NCT00396071
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Diabetes Zentrum Bad Lauterberg Bad Lauterberg im Harz, Germany
- Novartis Pharmaceuticals Basel, Switzerland